Evidence map›Paper›PMID 31308147›Full record

ArticleMolecular cancer research : MCR2019

HILPDA Regulates Lipid Metabolism, Lipid Droplet Abundance, and Response to Microenvironmental Stress in Solid Tumors.

Matthew J VandeKopple, Jinghai Wu, Erich N Auer, Amato J Giaccia, Nicholas C Denko, Ioanna Papandreou

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Lipidomic Remodeling by HILPDA in Granulosa Cells Impairs Ovarian Reserve Through Disruption of Mitochondrial and Endoplasmic Reticulum Homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Select intratumoral riboflavin-auxotrophicProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. HIG-2 promotes glioma stemness and radioresistance mediated by IGFBP2-rich microparticles in hypoxia.Apoptosis : an international journal on programmed cell death · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Applications of organoid technology to brain tumors.CNS neuroscience & therapeutics · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew J VandeKoppleDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Jinghai WuDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Erich N AuerDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.ORCID 0000-0002-1465-1897
Amato J GiacciaDepartment of Radiation Oncology, Stanford University, Stanford, California.
Nicholas C DenkoDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Ioanna PapandreouDepartment of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Ioanna.papandreou@osumc.edu.ORCID 0000-0002-4458-6010
The Ohio State University · USStanford University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI WANCAI YANG · 1985 to 2026
$132.3M
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor GrowthR35CA197713 · NCI · STANFORD UNIVERSITY · PI GIACCIA, AMATO J. · 2015 to 2021
$5.3M
HILPDA and lipid metabolism in colorectal cancerR03CA191653 · NCI · OHIO STATE UNIVERSITY · PI PAPANDREOU, IOANNA · 2015 to 2016
$154k
NCI NIH HHS P30 CA016058NCI NIH HHS R03 CA191653NCI NIH HHS R35 CA197713
6 · The paper itself

Abstract

Accumulation of lipid droplets has been observed in an increasing range of tumors. However, the molecular determinants of this phenotype and the impact of the tumor microenvironment on lipid droplet dynamics are not well defined. The hypoxia-inducible and lipid droplet associated protein HILPDA is known to regulate lipid storage and physiologic responses to feeding conditions in mice, and was recently shown to promote hypoxic lipid droplet formation through inhibition of the rate-limiting lipase adipose triglyceride lipase (ATGL). Here, we identify fatty acid loading and nutrient deprivation-induced autophagy as stimuli of HILPDA-dependent lipid droplet growth. Using mouse embryonic fibroblasts and human tumor cells, we found that genetic ablation of HILPDA compromised hypoxia-fatty acid- and starvation-induced lipid droplet formation and triglyceride storage. Nutrient deprivation upregulated HILPDA protein posttranscriptionally by a mechanism requiring autophagic flux and lipid droplet turnover, independent of HIF1 transactivation. Mechanistically, loss of HILPDA led to elevated lipolysis, which could be corrected by inhibition of ATGL. Lipidomic analysis revealed not only quantitative but also qualitative differences in the glycerolipid and phospholipid profile of HILPDA wild-type and knockout cells, indicating additional HILPDA functions affecting lipid metabolism. Deletion studies of HILPDA mutants identified the N-terminal hydrophobic domain as sufficient for targeting to lipid droplets and restoration of triglyceride storage.

Indexed as

AcyltransferasesAnimalsFemaleHCT116 CellsHeterograftsHumansLipaseLipid DropletsLipid MetabolismMiceMice, KnockoutMice, NudeNeoplasm ProteinsNeoplasmsRNA, MessengerTumor MicroenvironmentAcyltransferasesHILPDA protein, humanLipaseNeoplasm ProteinsPNPLA2 protein, humanRNA, Messenger

Identifiers

PMID31308147
PMCPMC6774878
OpenAlexW2957206257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.